GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anavex Life Sciences Corp (STU:12X1) » Definitions » Pre-Tax Income

Anavex Life Sciences (STU:12X1) Pre-Tax Income : €-43.16 Mil (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Anavex Life Sciences Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Anavex Life Sciences's pretax income for the three months ended in Dec. 2024 was €-11.57 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was €-43.16 Mil. Anavex Life Sciences's pretax margin was %.


Anavex Life Sciences Pre-Tax Income Historical Data

The historical data trend for Anavex Life Sciences's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anavex Life Sciences Pre-Tax Income Chart

Anavex Life Sciences Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -22.29 -32.00 -48.10 -44.51 -38.75

Anavex Life Sciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.91 -9.61 -11.41 -10.58 -11.57

Competitive Comparison of Anavex Life Sciences's Pre-Tax Income

For the Biotechnology subindustry, Anavex Life Sciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anavex Life Sciences's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anavex Life Sciences's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Anavex Life Sciences's Pre-Tax Income falls into.


;
;

Anavex Life Sciences Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Anavex Life Sciences's Pretax Income for the fiscal year that ended in Sep. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-47.575+2.234+0+6.595+0.0010000000000048
=-38.75

Anavex Life Sciences's Pretax Income for the quarter that ended in Dec. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-12.969+0.072+0+1.331+0
=-11.57

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-43.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anavex Life Sciences  (STU:12X1) Pre-Tax Income Explanation

Anavex Life Sciences's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-11.566/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anavex Life Sciences Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Anavex Life Sciences's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Anavex Life Sciences Business Description

Traded in Other Exchanges
Address
630 5th Avenue, 20th Floor, New York, NY, USA, 10111
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Anavex Life Sciences Headlines

No Headlines